Continuous blood glucose monitoring market seen reaching $26.11 billion by 2030

The Business Research Company says the global continuous blood glucose monitoring market will rise from $16.29 billion in 2026 to $26.11 billion by 2030 as diabetes cases climb and sensor technology improves. North America led the market in 2025, while home monitoring, digital health integration and AI-driven analytics are expected to drive the next phase of growth.

Why it matters: - Continuous blood glucose monitoring is becoming a core diabetes-management tool as patients and clinicians look for real-time data instead of finger-prick testing. - The market’s projected jump to $26.11 billion by 2030 points to sustained demand across hospitals, clinics and home care. - Rising diabetes rates, especially among younger patients, are expanding the pool of people who need continuous monitoring.

What happened: - The Business Research Company published its Continuous Blood Glucose Monitoring Market Report 2026, covering market size, trends and a global forecast for 2026-2035. - The report estimates the market will grow from $14.87 billion in 2025 to $16.29 billion in 2026. - The same report projects the market will reach $26.11 billion by 2030. - North America held the dominant market position in 2025.

The details: - The 2026 market forecast implies 9.6% growth from 2025 to 2026. - The 2030 forecast implies a 12.5% compound annual growth rate. - The report points to implantable and flash glucose sensors as major growth drivers. - Home care and remote monitoring adoption are expected to add momentum. - Integration with digital health platforms is becoming more important. - AI-driven predictive analytics is also shaping the market. - The report highlights increased acceptance of continuous glucose monitors, smartphone app connectivity and wearable-device links. - Growth is also tied to expansion in home-based diagnostics, minimally invasive and implantable sensor development, and real-time alerts and analytics. - CGM systems place a sensor beneath the skin and track glucose levels in real time. - The devices provide ongoing feedback and alerts when glucose gets too high or too low. - The report says that helps people with diabetes manage the condition more effectively than traditional finger-prick testing. - Diabetes remains the main demand driver because continuous monitoring helps identify patterns and trends in blood sugar changes. - The UK National Health Service reported diabetes cases among people under 40 rose from 173,166 in 2022 to 216,440 in 2023. - The report also cites digital health tools, remote monitoring, healthcare infrastructure investment, and personalized and preventive care as growth factors. - The study covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis, future trend analysis, and updated graphics and tables. - Download a free sample of the report. - View the full market report.

Between the lines: - The forecast suggests CGM is moving from a specialized diabetes tool toward a broader, more connected chronic-care platform. - North America’s lead shows the market is already mature in some regions, but rising awareness and access could accelerate growth elsewhere. - The emphasis on AI, wearables and remote monitoring indicates the next wave of competition will likely center on convenience, accuracy and data integration.

What's next: - The report expects adoption to keep rising as more patients use home-based and remote monitoring tools. - Sensor innovation and tighter links with consumer devices are likely to remain key product themes. - Broader diabetes prevalence should continue to support demand through 2030. - The Business Research Company is offering expanded 2026 report features, including forecasting dashboards and updated graphics.